FRANKLIN LAKES, N.J. (AP) - Becton Dickinson and Co. said Friday it bought molecular diagnostic test maker HandyLab Inc. for $275 million.

The company first announced the acquisition in October.

The company has said it would run tests for infections such as MRSA on a diagnostic test platform made by Ann Arbor, Mich.-based HandyLab. The product will be sold as a new version of Becton Dickinson's BD Max system.

Shares of Becton Dickinson rose 24 cents to close at $73.70.

Copyright 2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.